Metrics opens a new laboratory to support fast-track development of pharmaceutical products in North Carolina.

EMD Serono assigns operational changes.

FDA provides recommendations for submitting analytical procedures and methods validation data.

DIR Technologies will work with Pfizer to perform a three-month trial of the company's packaging integrity testing systems.

Ben Venue issues a voluntary patient level recall of Acetylcysteine Solution 10% due to glass particle in vial.

Thirteen companies are accepted for participation in the supply chain program.

Ecolab's Shield Medicare division will now be called Ecolab Contamination Control.

Tandem Diabetes Care expands its voluntary recall of select lots of insulin cartridges used with t:slim insulin pump.

Cobra Biologics' GMP Compliance Certification has been extended to include QC testing.

Mallinckrodt acquires Cadence Pharmaceuticals for $1.3 million.

EMA releases an update on its flu vaccine guidance.

EMA and the European Commission revise Q&A document on implementation of marketing authorization guidelines.

The companies will pre-promote their auto-injection syringe inspection platform at ATX West.

Cytovance Biologics continues to work on the expansion of a manufacturing operations and GMP warehousing facility in Oklahoma.

Mylan Pharmaceuticals launches Hertraz, the world's first trastuzumab biosimilar in India.

Novartis is named among the 2014 Corporate Knights Global 100.

Sartorius appoints Michael Melingo to head marketing, sales, and services of the Lab Products & Services Division.

Shimadzu's new Solution Center features additional research space.

In first official visit to India, FDA commissioner to discuss ongoing collaboration on drug programs.

BioOutsource will open a new Biosimilar Center of Excellence in Scotland.

Partners MPI Research, inviCRO, and 3D Imaging announce name of new facility for molecular imaging, autoradiography, and animal modeling.

NIH, 10 biopharmaceutical companies, and several nonprofit organizations form a partnership to develop new treatments earlier for Alzheimer's, type 2 diabetes, and autoimmune disorders.

Thermo Fisher Scientific outlines new business segments with acquisition of Life Technologies.

Neolpharma opens its new Development and Innovation Center (CEDIPROF) for pharmaceutical products in Puerto Rico.

Edison and DSP partner to develop drugs targeting cellular energy metabolism.

Last year, the Turkish Government unveiled plans to position the country in the top 10 most-preferred locations for R&D investment in the pharmaceutical sector by 2023. This article provides an overview of the incentives introduced under the Technopolis Law and the R&D Act.

PDA works with FDA to create pharmaceutical quality metrics.

ISPE and PDA take on the challenge of recommending quality metrics.